Clinical Trial

Flow-Controlled Ventilation to Improve Postoperative Pulmonary Outcome After Thoracic Surgery

Study acronym: PROFLOW-THORAC
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
In an international multicenter randomized clinical pilot trial, intraoperative flow-controlled ventilation (FCV) will be compared with volume-controlled ventilation (VCV) in patients scheduled for (open, video- or robot-assisted) thoracic surgery with one-lung ventilation (OLV). This pilot trial is designed to test the feasibility and safety of FCV during all phases of intraoperative ventilation, and in particular during OLV, and to inform the design of a future trial testing the efficacy of FCV with regard to postoperative outcomes, including postoperative pulmonary complications (PPC). The ventilation modes are conducted with CE-marked medical devices (anesthesia ventilators or medical ventilators), however these medical devices themselves are not under investigation. All CE-marked standard medical devices from varied manufacturers in use at the participating study centers will be used in full accordance with their instructions for use. FCV has shown safety and feasibility in various surgical settings, including thoracic surgery with OLV, however its feasibility in a multicenter trial has not been investigated yet.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2026-06-01; most recent amendment 2026-06-28.
Trial Details
NCT Number NCT07623395
Lead Sponsor Cantonal Hospital of St. Gallen
Conditions Mechanical Ventilation, Postoperative Pulmonary Complications (PPCs)
Enrollment 140 participants
Start Date 2026-09-01
Primary Completion 2027-09-01 (estimated)
Study Completion 2027-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-01